Neeru Bhardwaj

96 weeks treatment of tenofovir alafenamide vs. tenofovir disoproxil fumarate for hepatitis B virus infection

Kosh Agarwal, Maurizia Rossana Brunetto, Wai Kay Seto et al. · Journal of Hepatology · 2018 · 423 citations · Full text

Pharmacy, Infectious Diseases, Pharmacology +10

Global epidemiology of HCV subtypes and resistance-associated substitutions evaluated by sequencing-based subtype analyses

Tania M. Welzel, Neeru Bhardwaj, Charlotte Hedskog et al. · Journal of Hepatology · 2017 · 134 citations · Full text

Life Sciences, Infectious Diseases, Molecular Genetics +17

HIV-1 Infection Leads to Increased Transcription of Human Endogenous Retrovirus HERV-K (HML-2) Proviruses<i>In Vivo</i>but Not to Increased Virion Production

Neeru Bhardwaj, Frank Maldarelli, John W. Mellors et al. · Journal of Virology · 2014 · 85 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +11

Differential Expression of HERV-K (HML-2) Proviruses in Cells and Virions of the Teratocarcinoma Cell Line Tera-1

Neeru Bhardwaj, Meagan Montesion, Farrah Roy et al. · Viruses · 2015 · 71 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

No Resistance to Tenofovir Alafenamide Detected through 96 Weeks of Treatment in Patients with Chronic Hepatitis B Infection

Andrea L. Cathcart, Henry Lik‐Yuen Chan, Neeru Bhardwaj et al. · Antimicrobial Agents and Chemotherapy · 2018 · 60 citations · Full text

Life Sciences, Infectious Diseases, Pharmacology +17